Annual Report 2016

Belgian Health Care Knowledge Centre

Who are we?

The KCE (Belgian Health Care Knowledge Centre) is an independent research centre that provides scientific advice on topics related to the organisation of health care. In general, these topics are proposed by public authorities, universities, professional associations, etc.

The mission of the KCE is to provide rigorous and objective scientific analysis and studies on the basis of which public authorities or health care providers can base their decisions regarding health care and health insurance. KCE is therefore expected to offer optimal solutions for care that are both accessible to all and of high quality, in a context of increasing demand and a limited budget.

However, that is where the role of KCE ends. It is not involved in the subsequent political choices or in their implementation, even when this implies that its advices are adjusted by the policy makers to the reality of the field…

KCE is a type B parastatal organisation. This status guarantees total independence from the subsidiary powers, who essentially are the federal authorities (INAMI for 75% and FPS Health and Social Security, together for 25%). In addition, some specific European subsidies cover KCE’s involvement in international research networks and projects.

What does KCE stand for?

The Belgian Health Care Knowledge Centre has chosen the acronym KCE, which is a contraction of the words Kenniscentrum (Dutch) – Centre d’Expertise (French)

What do we do?

The KCE mission encompasses five areas of expertise:


  • Organisation and financing of health care in the broadest sense – Health Services Research
  • Evaluation of medical technologies – Health Technology Assessment
  • The production of clinical practice guidelines and their constant adaptation to new scientific developments – Good Clinical Practice
  • Setting up and coordination of the Belgian non-commercial clinical research programme – KCE Trials programme
  • Creation of accurate methodological manuals to establish validated working methods for all health care and public health researchers – Methods

In 2016, KCE published 19 reports.

Our Values

We want to be:





to achieve a healthcare that is

of high quality



patient oriented

The Key Figures

reports published in 2016

active members since 2016

visits on the KCE website in 2016

Our Board of Directors

Our Board of Directors (hereinafter, the “Board”), consists of representatives of the public authorities and the most important actors in healthcare, health insurance and patient associations, in a balanced composition. At each Board meeting our new finalised reports are presented. The scientific content is in principle not subject to modification, except on the basis of quantifiable methodological arguments. The political recommendations, based upon the scientific work, are then discussed, sometimes nuanced, and approved by a simple majority, when voting turns out to be necessary.

Finally, KCE is legally obliged to publish all of its results within one month of their approval by the Board, which is an additional guarantee for our transparency.

Report list 2016

Quality indicators for the management of lung cancer

Report 266 :...
Read more

Belrai suite of instruments

Report 262 :...
Read more

Multi criteria decision analysis to select priority diseases for Newborn blood screening.

Report 267 :...
Read more

Future scenarios about drug development and drug pricing

Report 271 :...
Read more

Governance models for hospital collaborations

Report 277 :...
Read more

Financial compensation for persons infected by a contaminated blood transfusion

Report 273 :...
Read more

Organisation and payment of emergency care services

Report 263 :...
Read more

Multi-criteria decision analysis

Report 272 :...
Read more

How to improve the detection of child abuse in Belgium

Report 269 :...
Read more

Clustering pathology groups on hospital stay similarity

Report 270 :...
Read more

Guideline on the management of rectal cancer

Report 260 :...
Read more

Ovarian cancer: diagnosis, treatment and follow-up

Report 268 :...
Read more

Left ventricular assist devices in the treatment of end-stage heart failure

Report 264 :...
Read more

Economic evaluation of novel direct acting antiviral (DAA) treatment strategies for chronic hepatitis C

Report 276 :...
Read more

Elective caesarean section in low-risk women at term: consequences for mother and offspring

Report 275 :...
Read more

The role of biomarkers in ruling out cerebral lesions in mild cranial trauma

Report 261 :...
Read more

Use of pneumococcal vaccines in the elderly: an economic evaluation

Report 274 :...
Read more

Download the Annual Report 2016

Share This